Literature DB >> 12123488

The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.

J H Moore1, M E Smolkin, J M Lamb, N J Brown, D E Vaughan.   

Abstract

Thrombus formation and degradation is partly due to a complex interplay between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1). There is accumulating evidence that plasma levels of t-PA and PAI-1 may be influenced by an interaction between the fibrinolytic and renin-angiotensin systems. The goal of this study was to conduct an exploratory data analysis to determine whether there is evidence that the relationship (i.e. correlation) between plasma t-PA and PAI-1 is influenced by interactive effects of the angiotensin converting enzyme (ACE) insertion/deletion (I/D) and plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphisms in a sample of 50 unrelated African Americans and 117 unrelated Caucasians. In a single-locus analysis, no evidence for heterogeneity of plasma t-PA and PAI-1 correlations among either ACE I/D or PAI-1 4G/5G genotypes was detected. However, using the combinatorial partitioning method for exploratory data analysis, we identified evidence that is suggestive of heterogeneity of plasma t-PA and PAI-1 correlations among multilocus ACE I/D and PAI-1 4G/5G genotypes in African American females, Caucasian females, Caucasian males, but not African American males. From these results, we propose as a working hypothesis that the correlation between plasma t-PA and PAI-1 may be dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms. This study supports the idea that interactions between the fibrinolytic and renin-angiotensin systems play an important role in the genetic architecture of plasma t-PA and PAI-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123488     DOI: 10.1034/j.1399-0004.2002.620107.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.

Authors:  Folkert W Asselbergs; Scott M Williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; Gerjan Navis; Douglas E Vaughan; Wiek H van Gilst; Jason H Moore
Journal:  Genomics       Date:  2007-01-05       Impact factor: 5.736

2.  Analysis of gene-gene interactions.

Authors:  Diane Gilbert-Diamond; Jason H Moore
Journal:  Curr Protoc Hum Genet       Date:  2011-07

3.  Shadows of complexity: what biological networks reveal about epistasis and pleiotropy.

Authors:  Anna L Tyler; Folkert W Asselbergs; Scott M Williams; Jason H Moore
Journal:  Bioessays       Date:  2009-02       Impact factor: 4.345

4.  Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems.

Authors:  John P Bentley; Folkert W Asselbergs; Christopher S Coffey; Patricia R Hebert; Jason H Moore; Hans L Hillege; Wiek H van Gilst
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

5.  The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases.

Authors:  A Geert Heidema; Jolanda M A Boer; Nico Nagelkerke; Edwin C M Mariman; Daphne L van der A; Edith J M Feskens
Journal:  BMC Genet       Date:  2006-04-21       Impact factor: 2.797

Review 6.  Serpins in thrombosis, hemostasis and fibrinolysis.

Authors:  J C Rau; L M Beaulieu; J A Huntington; F C Church
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

7.  ACE genotype, risk and causal relationship to stroke: implications for treatment.

Authors:  Agnieszka Slowik; Tomasz Dziedzic; Joanna Pera; Dorota Wloch; Grzegorz Kopec; Andrzej Szczudlik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06

8.  Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.

Authors:  Agnese Ozolina; Eva Strike; Liene Nikitina-Zake; Inta Jaunalksne; Angelika Krumina; Romans Lacis; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2015-09-04       Impact factor: 2.217

9.  Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis.

Authors:  Sara Santos de Carvalho; Ana Cristina Simões e Silva; Adriano de Paula Sabino; Fernanda Cristina Gontijo Evangelista; Karina Braga Gomes; Luci Maria SantAna Dusse; Danyelle Romana Alves Rios
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

10.  The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise.

Authors:  Adam M Coughlin; Paul R Nagelkirk; Jamie A Cooper; Chad M Paton; Karen H Friderici; Byron A Wingerd; James M Pivarnik; Christopher J Womack
Journal:  Int J Exerc Sci       Date:  2018-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.